Literature DB >> 11241413

Mucin gene transcripts in benign and borderline mucinous tumours of the ovary: an in situ hybridization study.

F Boman1, M P Buisine, A Wacrenier, D Querleu, J P Aubert, N Porchet.   

Abstract

Mucinous tumours of the ovary are characterized by mucin-secreting cells exhibiting a variable endocervical, intestinal, gastric or pancreatobiliary phenotype as ascertained by microscopy, electron microscopy, histochemistry or immunohistochemistry. The molecular mechanisms underlying the tumourigenesis process are not well understood. The mucin glycoproteins expressed by ovarian mucinous tumours have not been fully characterized, but mucins are known to be implicated in tumour progression in various epithelial neoplasms. The purpose of this study was to evaluate the expression of mucin genes (MUC1, MUC2, MUC3, MUC4, MUC5AC, MUC5B, MUC6) in ovarian mucinous tumour cells, to relate MUC gene expression to the histological diagnosis, and to compare the expression patterns with those observed in normal tissues. The expression of mucin genes was evaluated by in situ hybridization in 21 mucinous tumours (11 adenomas and ten borderline tumours). Heterogeneity of expression correlated with morphological heterogeneity. Intense expression of the MUC5AC gene, suggesting a gastric surface cell phenotype, was demonstrated in 18/21 tumours (86%). Goblet cells expressing the MUC2 gene and columnar cells expressing the MUC3 gene were consistent with an intestinal phenotype, which was observed in 15 tumours (71%) including nine adenomas and six borderline tumours. Major expression of MUC4 and MUC5B consistent with an endocervical phenotype was observed in seven benign (64%) and three borderline (30%) tumours. In all, the MUC profiles suggested gastrointestinal-type cells in 13 cases (62%), gastric-type cells in five cases (24%), and intestinal-type cells in two cases (one benign, one borderline) (9%); the results were inconclusive in one borderline tumour (5%). It is concluded that gastric and, to a lesser degree, intestinal differentiation are early and almost constant events in ovarian mucinous tumourigenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11241413     DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH798>3.0.CO;2-9

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  9 in total

Review 1.  Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer.

Authors:  Ajay P Singh; Shantibhusan Senapati; Moorthy P Ponnusamy; Maneesh Jain; Subodh M Lele; John S Davis; Steven Remmenga; Surinder K Batra
Journal:  Lancet Oncol       Date:  2008-11       Impact factor: 41.316

Review 2.  MUC1 in endometriosis and ovarian cancer.

Authors:  Anda M Vlad; Iulia Diaconu; Kira R Gantt
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells.

Authors:  M P Ponnusamy; I Lakshmanan; M Jain; S Das; S Chakraborty; P Dey; S K Batra
Journal:  Oncogene       Date:  2010-08-09       Impact factor: 9.867

4.  MUC4 stabilizes HER2 expression and maintains the cancer stem cell population in ovarian cancer cells.

Authors:  Moorthy P Ponnusamy; Parthasarathy Seshacharyulu; Arokiapriyanka Vaz; Parama Dey; Surinder K Batra
Journal:  J Ovarian Res       Date:  2011-04-26       Impact factor: 4.234

5.  MUC2 polymorphisms are associated with endometriosis development and infertility: a case-control study.

Authors:  Cherry Yin-Yi Chang; Yi Chen; Wu-Chou Lin; Chih-Mei Chen; Chih-Ping Chen; Shan-Chih Lee; Jim Jinn-Chyuan Sheu; Fuu-Jen Tsai
Journal:  BMC Med Genet       Date:  2012-03-15       Impact factor: 2.103

6.  The O-Linked Glycome and Blood Group Antigens ABO on Mucin-Type Glycoproteins in Mucinous and Serous Epithelial Ovarian Tumors.

Authors:  Varvara Vitiazeva; Jayesh J Kattla; Sarah A Flowers; Sara K Lindén; Pushpa Premaratne; Birgitta Weijdegård; Karin Sundfeldt; Niclas G Karlsson
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

7.  Mucins in ovarian cancer diagnosis and therapy.

Authors:  Subhash C Chauhan; Deepak Kumar; Meena Jaggi
Journal:  J Ovarian Res       Date:  2009-12-24       Impact factor: 4.234

8.  Alterations in mucin expression in ovarian mucinous tumors: immunohistochemical analysis of MUC2, MUC5AC, MUC6, and CD10 expression.

Authors:  Kenichi Hirabayashi; Masanori Yasuda; Hiroshi Kajiwara; Johbu Itoh; Masaki Miyazawa; Takeshi Hirasawa; Toshinari Muramatsu; Masaru Murakami; Mikio Mikami; Robert Yoshiyuki Osamura
Journal:  Acta Histochem Cytochem       Date:  2008-04-26       Impact factor: 1.938

9.  High MUC2 expression in ovarian cancer is inversely associated with the M1/M2 ratio of tumor-associated macrophages and patient survival time.

Authors:  Yi-feng He; Mei-ying Zhang; Xin Wu; Xiang-jun Sun; Ting Xu; Qi-zhi He; Wen Di
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.